Tryptamine Therapeutics Ltd. is a clinical-stage biotechnology company, which engages in bringing transformative medicine with known safety profiles to diseases with no effective first-line treatments. The company was headquartered in Kelowna, Australia.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company